VIJAYA

Vijaya Diagnostic Centre Balance Sheet

₹1,475.00+0.57%
Market cap
₹15,177 crore
P/E
81.0
P/B
15.86
ROE
19.7%
Dividend yield
0.14%

As of Mar 2022, Vijaya Diagnostic Centre had total assets of ₹13,700 crore and borrowings of ₹1,200 crore, against shareholders' equity of ₹9,000 crore — a debt-to-equity ratio of 0.13. Borrowings rose 384.73% from Mar 2023.

Vijaya Diagnostic Centre balance sheet

As at each financial year end, newest first. H1 = half-year.

Vijaya Diagnostic Centre balance sheet (₹ crore)
ItemMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity capital50010.2110.2310.2610.29
Reserves8,500480588711864
Borrowings1,200248259320423
Other liabilities3,50059.2263.66155127
Total liabilities13,7008539831,2741,507
Fixed assets6,500550615802977
Capital work in progress400100100100100
Investments2,500171197255301
Other assets4,300256295382452
Total assets13,7008539831,2741,507

Balance sheet ratios

Debt to equity
0.13

Source: Company filings (consolidated), in ₹ crore. Data as of 7 October 2026. How this data is compiled.

Vijaya Diagnostic Centre balance sheet — frequently asked questions

What is the total debt of Vijaya Diagnostic Centre?

Vijaya Diagnostic Centre reported borrowings of ₹1,200 crore as of Mar 2022, compared with ₹248 crore as of Mar 2023.

What is Vijaya Diagnostic Centre's debt-to-equity ratio?

Based on the Mar 2022 balance sheet, Vijaya Diagnostic Centre's debt-to-equity ratio is 0.13 — borrowings of ₹1,200 crore against equity capital and reserves of ₹9,000 crore.

What are Vijaya Diagnostic Centre's total assets?

Vijaya Diagnostic Centre's total assets were ₹13,700 crore as of Mar 2022, including fixed assets of ₹6,500 crore and investments of ₹2,500 crore.

Same Data For Peers

Trade Vijaya Diagnostic Centre With ATS

Track VIJAYA live and place orders from the Pocket app or the Pocket Web terminal with an ATS trading and demat account.

Figures are for information only and are not investment advice or a recommendation to buy, sell or hold any security. Investments in securities are subject to market risks; read all related documents carefully before investing.